These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7263761)

  • 21. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.
    van Landeghem AA; Poortman J; Nabuurs M; Thijssen JH
    Cancer Res; 1985 Jun; 45(6):2900-6. PubMed ID: 3986816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems.
    Berthois Y; Pourreau-Schneider N; Gandilhon P; Mittre H; Tubiana N; Martin PM
    J Steroid Biochem; 1986 Dec; 25(6):963-72. PubMed ID: 3025520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estrogen receptors of the human breast].
    El'tsina NV
    Vopr Onkol; 1978; 24(8):108-15. PubMed ID: 358579
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors.
    Mercer WD; Edwards DP; Chamness GC; McGuire WL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4644-52. PubMed ID: 7030480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans.
    Wittliff JL; Hilf R; Brooks WF; Savlov ED; Hall TC; Orlando RA
    Cancer Res; 1972 Sep; 32(9):1983-92. PubMed ID: 4345046
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of membrane estrogen binding proteins from rabbit uterus.
    Monje P; Boland R
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):75-84. PubMed ID: 10195694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and immunological characterization of estrogen binding components in human neoplastic adrenocortical tissues.
    Nakao M; Sato B; Koga M; Noma K; Kishimoto S; Matsuda M; Sonoda T; Matsumoto K
    J Steroid Biochem; 1986 Jul; 25(1):1-9. PubMed ID: 3747509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and quantitation of human hepatic estrogen receptor.
    Porter LE; Elm MS; Van Thiel DH; Dugas MC; Eagon PK
    Gastroenterology; 1983 Apr; 84(4):704-12. PubMed ID: 6825981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
    Hansen ER; Brooks SC
    Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity cytosol binding site(s) for antiestrogens in two human breast cancer cell lines and in biopsy specimens devoid of estrogen receptors.
    Chouvet C; Saez S
    J Steroid Biochem; 1984 Dec; 21(6):755-61. PubMed ID: 6527539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
    Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
    Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
    Dittadi R; Meo S; Amoroso B; Gion M
    Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochemical demonstration of estrogen binding sites in breast cancer by estradiol covalently linked to horseradish peroxidase.
    Jansson SE; Gripenberg J; Karonen SL; Wasenius VM; Pantzar P; Kontula K; Kärkkäinen J; Adlercreutz H
    Eur J Cancer Clin Oncol; 1985 May; 21(5):625-30. PubMed ID: 3891366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on mechanisms of estrogen and antiestrogen action in human breast cancer.
    Horwitz KB; McGuire WL
    Recent Results Cancer Res; 1980; 71():45-58. PubMed ID: 6988916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and assay of progesterone receptor in human mammary carcinoma.
    Pichon MF; Milgrom E
    Cancer Res; 1977 Feb; 37(2):464-71. PubMed ID: 832270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.